GTBPVSSOPH• 7 Days (Normalized)
GTBP vs SOPH (GT Biopharma Inc. vs SOPHiA GENETICS SA)
Showing Closing Date Range from Sep 28 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.1
-10.29%
GT Biopharma Inc.
Normalized Baseline0.00%
SOPH Performance $8.07
-4.95%
SOPHiA GENETICS SA
Normalized Baseline0.00%
Alpha Spread Margin SOPH LEADS
-5.34 pts
SOPH outperforming by 5.34 percentage points
GTBPSOPH
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP SOPH
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(4 dates)
| Date | GTBP Price | GTBP Gain (%) | SOPH Price | SOPH Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $6.10 | -10.29% | $8.07 | -4.95% | -5.34% |
| Sep 30, 2026 | $- | $8.38 | -1.30% | - | |
| Sep 29, 2026 | $6.88 | +1.10% | $8.30 | -2.24% | +3.34% |
| Sep 28, 2026 | $6.80 | +0.00% | $8.49 | +0.00% | +0.00% |